Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2025-01-23 (globenewswire.com)
Pharmaceutical Regulatory Affairs Research Report 2025-2030: Entry of Companies into the Global Market Fueling Growth
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By Category, By Indication, By Development Stage, By Company Size, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.
Read more
2024-11-02 (expresspharma.in)
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Read more
2024-09-17 (newscast.jp)
Global medical contract research organization market expected to reach USD 80.45 billion by 2032: Key players and technological advances accelerating drug discovery
The global contract research organization (CRO) market remains steady at US$43.76 billion. According to recent market analysis, it is expected to grow to $80.45 billion in 10 years, at a compound annual growth rate (CAGR) of 7%.
Read more
2024-01-16 (biovoicenews.com)
Parexel announces strategic alliance with Japanese Foundation for Cancer Research - BioVoiceNews
With experience spanning more than 115 years, JFCR is Japan’s first and largest medical organization dedicated to cancer care
Read more
2022-12-15 (globenewswire.com)
Parexel Teams with MyEyeDr. to Increase Patient Access and Participation in Ophthalmology Clinical Trials
New collaboration leverages MyEyeDr.’s 850+ offices across the US to refer patients into ophthalmology and other therapeutic area clinical trials, expands...
Read more
2022-12-15 (ophthalmologytimes.com)
Parexel teams with MyEyeDr. to increase patient access and participation in ophthalmology clinical trials
The company’s collaboration leverages MyEyeDr.’s 850+ offices across the United States to refer patients into ophthalmology and other therapeutic area clinical trials, expands Parexel’s Community Alliance Network to bring trials to patients where they are.
Read more
2022-12-15 (koin.com)
Parexel Teams with MyEyeDr. to Increase Patient Access and Participation in Ophthalmology Clinical Trials
Reporting Portland and Vancouver area breaking news and weather stories to make Oregon and Southwest Washington a better place to live
Read more
2022-12-15 (globenewswire.com)
Parexel Teams with MyEyeDr. to Increase Patient Access and Participation in Ophthalmology Clinical Trials
New collaboration leverages MyEyeDr.’s 850+ offices across the US to refer patients into ophthalmology and other therapeutic area clinical trials, expands...
Read more
2022-06-16 (globenewswire.com)
Parexel Expands Patient Access to Clinical Trials Through New Community Alliance Network
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across...
Read more